NCT07910084Toborzás még nem indult
Notification Of High-Risk Veterans for Access to Heart Failure Prevention
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. nov. 2.
Rövid összefoglaló (regiszter, angolul)
The purpose of this study is to learn whether connecting people at high risk for developing heart failure to a heart doctor (cardiologist) leads to greater use of treatments that can lower that risk. Heart failure is a condition in which the heart cannot pump blood as well as it should. The study focuses on Veterans living in rural areas, who often have a higher risk of heart failure and less access to heart care. The study team will use health record information to find Veterans who are at high risk for heart failure but do not yet have it, and who have health factors that could be improved with preventive treatment. The study team expects that telling these Veterans and their primary care providers about the elevated risk, and offering early cardiology care, will lead to greater use of treatments known to help prevent heart failure compared with usual care. The main questions the study aims to answer are: * Does informing a Veteran and their primary care provider about the Veteran's elevated risk for heart failure, and offering a referral to a cardiologist, increase the use of treatments known to help prevent heart failure? * Does having a care navigator reach out to Veterans and their primary care providers further help connect these Veterans to preventive care? Veterans in the study will be placed by chance into one of three groups. One group will receive usual care. A second group, along with their primary care provider, will be told about the Veteran's elevated risk for heart failure and offered a referral to a cardiologist. A third group will receive that same information and referral offer, plus outreach from a care navigator who can explain more about heart failure and the reason for the referral, answer questions, and help with scheduling.
- Állapot (regiszter)
- Toborzás még nem indult
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 250 (tervezett)
- Első benyújtás
- 2026. okt. 1.
- Kezdés
- 2026. okt.
- Elsődleges befejezés
- 2027. dec.
- Fő szponzor
- Palo Alto Veterans Institute for Research
- Betegségek
- Szívelégtelenség
- NCT-szám
- NCT07910084
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó
- Tervezett résztvevők: 250
- 2026. okt. és az elsődleges befejezés (2027. dec.) között
- Nincs megadott helyszín, ország nélkül
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Documented diagnosis of heart failure or atherosclerotic cardiovascular disease in the prior 2 years
- Documented diagnosis of a severe illness, including end-stage kidney disease, severe liver disease, metastatic cancer, or dementia, in the prior 2 years
- Visit with a VA cardiologist in the prior 2 years
- Insufficient data to calculate the PREVENT-HF 10-year risk from the prior 2 years
Kiket keres a vizsgálat
- Age 30-79 years
- Receive primary care at Veterans Affairs (VA) medical centers in the VA region including Northern and Central California, Nevada, Hawaii, and the Pacific Islands with at least 1 primary care visit in the prior 2 years
- Live in a rural location defined using established VA definitions of Rural-Urban Commuting Area (RUCA) codes \>1.1 - \<10.0 for "rural" and RUCA code 10.0 for "highly rural"
- Estimated 10-year risk of developing heart failure using the American Heart Association's PREVENT-HF equation ≥10%
- Presence of at least 3 opportunities to improve preventive care identified using electronic health records data from a prespecified opportunity list
Életkor a regiszterben: 30 év – 79 év · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.